Wang's (2021) research found that GDL can significantly increase the mini–mental state examination and monthly cognitive assessment scale scores in patients with mild cognitive impairment in WD, which may be related to a decrease in the serum levels of brain‐derived neurotrophic factor and vascular endothelial growth factor in patients. This evidence concerns the gene VEGFA and Wilson disease.